Search Tufts Medicine

Displaying 181 - 200 of 201
page
...
Apply for the neurology residency program at Tufts Medicine Tufts Medical Center in Boston and advance your career in neurology by learning from top doctors and surgeons.
department
The Department of Medicine helps us stand tall as one of the country’s leading health systems. While we take great pride in celebrating our department’s accomplishments, it’s our commitment to training tomorrow's primary care doctors, hospitalists and subspecialists that moves the needle of clinical care forward.
Articles
February 14, 2021
Animals are known to improve our mood and help calm us down. Learn more about pets and heart health from Dr. Brian Downey at Tufts MC.
page
...
The mission of Neonatal-Perinatal Medicine fellowship program at Tufts Medical Center is to create a comprehensive educational environment for our trainees to develop into excellent clinicians, researchers and teachers who will become leaders in their clinical and academic careers.
Press Releases
June 16, 2021
Helen Boucher, chief of the Division of Geographic Medicine and Infectious Diseases at Tufts Medical Center, professor of medicine at Tufts University School of Medicine and a director of the Stuart B. Levy Center for Integrated Management of Antimicrobial Resistance (Levy CIMAR), has been named to a new, joint position as interim dean for Tufts University School of Medicine and chief academic officer for Wellforce.
department
We are compassionate caregivers of patients living with serious illnesses, helping them manage their symptoms, navigate complex care systems and live a good life as long as possible.
Press Releases
April 20, 2021
While families reported disruptions and added stress, many also noted positive experiences that help build resilience in a survey conducted by the American Academy of Pediatrics and partnering organizations.
clinical trial
...

The purpose of this study is to characterize cardiac safety of Daratumumab, Cyclophosphamide, Bortezomib, and Dexamethasone (D-VCd) treatment regimens (Arm A: immediate daratumumab + VCd treatment and Arm B: daratumumab + deferred VCd) in newly diagnosed systemic amyloid light chain (AL) amyloidosis with cardiac involvement and to identify potential mitigation strategies for cardiac toxicity (cohort 1); to characterize the pharmacokinetics of subcutaneous (SC) daratumumab, among racial and ethnic minorities, including Black or African American, with newly diagnosed AL amyloidosis treated wi
Articles
August 7, 2024
Understand heart attack signs, symptoms, and prevention. Discover risk factors and learn what to do during a heart attack from the team at Tufts Medicine.
clinical trial
...

This phase III trial compares early treatment with venetoclax and obinutuzumab versus delayed treatment with venetoclax and obinutuzumab in patients with newly diagnosed high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival.
Articles
June 9, 2020
In response to the COVID-19 pandemic, routine in-person healthcare visits have been temporarily put on hold in efforts to conserve personal protective equipment and to maintain social distancing. As the Centers for Medicare & Medicaid Services eased restrictions on telehealth, virtual doctor visits have become the temporary norm.
page
...
Our principal investigators and trainees have received a number of honors and awards for their leadership and accomplishments in research that advances the understanding of preterm birth and its complications, maternal obesity and fetal and neonatal genomic medicine. We are grateful for the recognition from our peers and the honors bestowed on us by international and national associations and institutions for our contributions.
Publications + Awards
department
The Division of Geographic Medicine + Infectious Diseases is an international center of excellence in infectious disease, inpatient and outpatient treatment, research, and infectious disease fellowship training.